Lung Cancer Precision Medicine Trials: Adapting to Progress



Patients with lung cancer are benefiting from the boom in targeted and immune-based therapies. With a series of precision medicine trials, NCI is keeping pace with the rapidly changing treatment landscape for lung cancer.



Source link

Comments are closed.